Digitalni repozitorij raziskovalnih organizacij Slovenije

Izpis gradiva
A+ | A- | Pomoč | SLO | ENG

Naslov:Aminoglycoside antibiotics as first-line treatment of acute appendicitis and cholecystitis
Avtorji:ID Šetinc, Lučka (Avtor)
ID Pintar, Tadeja (Avtor)
ID Zafirovski, Aleksandar (Avtor)
ID Godnov, Uroš (Avtor)
ID Beović, Bojana (Avtor)
Datoteke:.pdf PDF - Predstavitvena datoteka, prenos (1,30 MB)
MD5: 1AA2C4CFCC4A87B38F15CBE10DBDF178
 
URL URL - Izvorni URL, za dostop obiščite https://www.tandfonline.com/doi/epdf/10.1080/1120009X.2024.2381158?needAccess=true
 
Jezik:Angleški jezik
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:Logo UKC LJ - Univerzitetni klinični center Ljubljana
Povzetek:We analyzed the efficacy and safety of aminoglycosides in a retrospective study of 415 patients with acute appendicitis and 277 patients with acute cholecystitis. The following variables increased the incidence of postoperative complications, defined as surgical site infection, recurrent intraabdominal infection, non-infectious post-operative complication, or death: age (p = 0.016 and 0.011), kidney disease (p = 0.019 and <0.001), and ASA Score (p < 0.001). The type of antibiotic therapy did not have a statistically significant effect on the incidence of postoperative complications in patients with acute appendicitis and cholecystitis (p = 0.561 and 0.547, respectively). A linear regression model showed a higher complication rate in patients with kidney disease (p = 0.014) and neoplasms (p = 0.013); the type of antibiotic therapy did not have a significant effect on the outcome (p = 0.765). There was no statistically significant difference in the post-treatment levels of creatinine in patients treated with aminoglycosides (gentamicin 3 mg/kg once daily) and in those who received other antibiotics (p = 0.75).
Ključne besede:aminoglycoside, antibiotics, antimicrobial resistance, intraabdominal infection, nephrotoxicity, risk factors
Status publikacije:Objavljeno
Verzija publikacije:Objavljena publikacija
Leto izida:2025
Št. strani:str. 307-316
Številčenje:Vol. 37, iss. 4
PID:20.500.12556/DiRROS-28634 Novo okno
UDK:616-07
ISSN pri članku:1973-9478
DOI:10.1080/1120009X.2024.2381158 Novo okno
COBISS.SI-ID:203877379 Novo okno
Opomba:Nasl. z nasl. zaslona; Opis vira z dne 8. 8. 2024;
Datum objave v DiRROS:26.03.2026
Število ogledov:179
Število prenosov:114
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
  
Objavi na:Bookmark and Share


Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše podrobnosti ali sproži prenos.

Gradivo je del revije

Naslov:Journal of chemotherapy
Skrajšan naslov:J. chemother.
Založnik:Edizioni riviste scientifiche, Maney Publishing
ISSN:1973-9478
COBISS.SI-ID:521573145 Novo okno

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:aminoglikozid, antibiotiki, protimikrobna odpornost, intraabdominalna okužba, nefrotoksičnost, dejavniki tveganja


Nazaj